2m 2m 2m 2m 2m 2m 2m
HUMACYTE (HUMA)
NASDAQ
$0.58-$0.006 (-1.02%)
Price as of Nov 11, 2026 7:46 PM EST- $163.9MMarket Cap
- -53.91%1-Year Change
- BiotechnologyIndustry
HUMACYTE (HUMA)
$0.58-$0.006 (-1.02%)
HUMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | +$0.13 (+29.61%) | ||
Open | $0.50 | ||
High | $0.60 | ||
Low | $0.49 | ||
Previous Close | $0.46 | ||
Volume | 15,665,927 | ||
30-Day Average Volume | 6,465,684 | ||
1-Week Change | 33.94% | ||
1-Month Change | 45.57% | ||
1-Year Change | -53.91% | ||
3-Year Change | -74.89% | ||
5-Year Change | -94.12% | ||
Fundamentals | |||
Shares Outstanding | 277.8M | ||
Total Assets | $125.6M | ||
Market Cap | $163.9M | ||
Enterprise Value | $136.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$15.5M | ||
Free Cash Flow | -$15.0M | ||
EBIT | -$15.4M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $57.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 133 | ||
P/B | 9 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue